Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 222-695-1 | CAS number: 3576-88-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- May - July 2009
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study with GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- not specified
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- 2,2'-iminobis[4,6-diamino-1,3,5-triazine]
- EC Number:
- 222-695-1
- EC Name:
- 2,2'-iminobis[4,6-diamino-1,3,5-triazine]
- Cas Number:
- 3576-88-3
- Molecular formula:
- C6H9N11
- IUPAC Name:
- N~2~-(4,6-diamino-1,3,5-triazin-2-yl)-1,3,5-triazine-2,4,6-triamine
- Reference substance name:
- melam
- IUPAC Name:
- melam
- Details on test material:
- Name of test material (as cited in study report): Melam
Chemical name: 2,2'-iminobis[4,6-diamino-1,3,5-triazine]
Lot No.: ACES062008
CAS No.: 3576-88-3
Appearance: Crystalline powder
Molecular formula and weight: C6H9N11, 235.21
Purity: 98.45%
pH: 9.6
Density: 1679 kg/m3 (at 20 °C)
Melting point: > 300 °C
Particle size: 0.138-30.200 µm
Manufacture date: Feb. 17,2009
Expiry date: Feb. 16,2010
Storage condition: Room temperature (21.7-24.9°C)
Handling and notice: Routine hygienic procedures will be used to ensure the health and safety of the personnel according to MSDS.
Receipt date: May 18, 2009
Residue treatment: Disuse after completion of the study
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: ORIENTBIO INC., Korea
- Age at study initiation: 8 weeks
- Weight at study initiation: 174.0-203.3 g
- Fasting period before study: approximately 16 hours, drinking water was not withheld
- Housing: Stainless steel wire cages, 260Wx350Dx21OH (mm); 1 animal
- Diet: Pelleted food for laboratory animal, provided ad libitum; Harlan Laboratories, Inc., U.S.A .
- Water: Public tap water in Cheongju-si was filtered and irradiated by ultraviolet rays.
Purified drinking water was provided ad libitum using a polycarbonate bottle (500 mL) in a quarantine room and an automatic watering system in an animal room. Samples of drinking water are analyzed for specified microorganism once a month and all environmental contaminants once
a year. The results were confirmed to meet the allowable standard of this facility.
- Acclimation period: 7 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20.1-23.7
- Humidity (%): 36.9-58.5
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): Cycle of 12 hours light and 12 hours dark (light on: 7 a.m., light off: 7 p.m.)
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- Water for injection
- Details on oral exposure:
- VEHICLE
- Lot no.: GBA9001
DOSE VOLUME APPLIED: 10 mL/kg b.w. - Doses:
- Dose level: 2000 mg/kg bw for steps 1 and 2.
Rationale for the selection of the starting dose: The starting dose level for this study was selected as the dose of 2000 mg/kg because the
LD50 value of test substance for rats is greater than 4000 mg/kg, according to the MSDS. - No. of animals per sex per dose:
- 3 females in step 1 and another 3 females on step 2.
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: prior to dosing (Day 0), on Days 1,3, 7, and the day of necropsy (Day 14).
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Statistics:
- Other than mean value calculations from the data obtained through this study, statistical analysis was not performed.
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- During the observation period, there were no deaths for any animals treated with 2000 mg/kg.
See Attachment Table 1 - Clinical signs:
- other: In 3 animals treated with 2000 mg/kg revealed compound-colored stool on Day 1 after administration, and then returned to a normal appearance on Day 2 after administration. It was considered to be test substance-related temporary changes. See Attachment Ta
- Gross pathology:
- At necropsy, no macroscopic findings were noted in all animals treated with 2000 mg/kg.
See Attachment Table 4
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- There were no deaths for any animal treated with 2000 mg/kg. No test substance-related effects were noted in clinical signs, body weights and necropsy in all animals treated with 2000 mg/kg.
Based on the results of acute oral toxicity study in rats, GHS classification of the test substance, Melam, was classified to be Category 5. - Executive summary:
This study was to assess the toxicity and GHS classification of the test substance, Melam, following a single oral administration to 8 weeks old female Sprague-Dawley rats. Test groups consisted of two groups at 2000 mg/kg of Steps 1 and 2, each step having three animals. All animals were monitored for clinical signs and body weight changes during the 14 days of observation period after administration. They were subjected to
gross necropsy at the end of the observation period.
There were no deaths for any animals treated with 2000 mg/kg. No test substance-related effects were noted in clinical signs, body weights and necropsy in all animals treated with 2000 mg/kg.
Based on the results of acute oral toxicity study in rats, GHS classification of the test substance, Melam, was classified to be Category 5.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
